Contemporary Percutaneous Treatment of Unprotected Left Main Coronary Stenoses
- 2 December 1997
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Circulation
- Vol. 96 (11), 3867-3872
- https://doi.org/10.1161/01.cir.96.11.3867
Abstract
Background Coronary artery bypass surgery (CABG) has been considered the therapy of choice for patients with unprotected left main (ULMT) coronary stenoses. Selected single-center reports suggest that the results of percutaneous intervention may now approach those of CABG. Methods and Results To assess the results of percutaneous ULMT treatment from a wide variety of experienced interventional centers, we requested data on consecutive patients treated after January 1, 1994, from 25 centers. One hundred seven patients were identified who were treated either electively (n=91) or for acute myocardial infarction (n=16). Of patients treated electively, 25% were considered inoperable, and 27% were considered high risk for bypass surgery. Primary treatment included stents (50%), directional atherectomy (24%), and balloon angioplasty (20%). Follow-up was 98.8% complete at 15±8 months. Results varied considerably, depending on presentation and treatment. For patients with acute myocardial infarction, technical success was achieved in 75%, and survival to hospital discharge was 31%. For elective patients, technical success was achieved in 98.9%, and in-hospital survival was strongly correlated with left ventricular ejection fraction ( P =.003). Longer-term event (death, infarction, or bypass surgery) -free survival was correlated with ejection fraction ( P <.001) and was inversely related to presentation with progressive or rest angina ( P <.001). Surgical candidates with ejection fractions ≥40% had an in-hospital survival of 98% and a 9-month event-free survival of 86±5%, whereas patients with ejection fractions Conclusions While results for selected patients appear promising, until early post–hospital discharge cardiac death can be better understood and minimized, percutaneous revascularization of ULMT stenosis should not be considered an alternative to bypass surgery for most patients. When percutaneous revascularization of ULMT is required, directional atherectomy and stenting appear to be the preferred techniques, and follow-up angiography 6 to 8 weeks after treatment is probably advisable.Keywords
This publication has 8 references indexed in Scilit:
- Percutaneous Treatment of Protected and Unprotected Left Main Coronary Stenoses With New Devices: Immediate Angiographic Results and Intermediate-Term Follow-UpJournal of the American College of Cardiology, 1997
- Increased Risk of Non-Q Wave Myocardial Infarction After Directional Atherectomy Is Platelet Dependent: Evidence From the EPIC TrialJournal of the American College of Cardiology, 1996
- Coronary risk factors measured in childhood and young adult life are associated with coronary artery calcification in young adults: The muscatine studyJournal of the American College of Cardiology, 1996
- Emergency rotational ablation of a calcified left main coronary artery stenosis in a patient with ischemic induced cardiogenic shockCatheterization and Cardiovascular Diagnosis, 1995
- Stenting for elastic recoil during coronary angioplasty of the left main coronary arteryThe American Journal of Cardiology, 1992
- Causes and correlates of death after unsupported coronary angioplasty: Implications for use of angioplasty and advanced support techniques in high-risk settingsThe American Journal of Cardiology, 1991
- Guidelines and indications for coronary artery bypass graft surgeryJournal of the American College of Cardiology, 1991
- Left main coronary angioplasty: Early and late results of 127 acute and elective proceduresThe American Journal of Cardiology, 1989